Electrostatic deposition assisted preparation, characterization and evaluation of chrysin liposomes for breast cancer treatment

• Published in: Drug development and industrial pharmacy Vol. 47; no. 5; pp. 809 - 819
• Main Authors: Deshmukh, Prashant K., Mutha, Rakesh E., Surana, Sanjay J.
• Format: Journal Article
• Language: English
• Published: Taylor & Francis 04-05-2021
• Subjects: chrysin; Electrostatic deposition; film hydration; in silico molecular docking; liposomes
• ISSN: 0363-9045; 1520-5762
• DOI: 10.1080/03639045.2021.1934873

Chrysin (CHR), a flavone found in multiple vegetables, fruits and mushrooms has been explored so far as a neurotropic, anti-inflammatory and anti-cancer biomolecule. Despite the stated therapeutic potential, low solubility and bioavailability limit its therapeutic benefit. To circumvent these drawbacks, development of chrysin liposomes (CLPs) is reported in the present investigation. The CLPs were developed by electrostatic deposition assisted film hydration method using chitosan/lecithin to protect chrysin in the nano-lipoidal shell. Developed CLPs were extensively characterized by DSC, XPRD, FE-SEM, TEM, particle size, polydispersity index, zeta potential, percent drug loading and encapsulation efficiency. These CLPs were further characterized by in vitro dissolution, in vivo bioavailability, in vitro anticancer and stability study. Suitable particle size, PDI and ZP implying stabilization of developed CLPs. The % DL and % EE was found to be 3.56 ± 0.13 and 90.5 ± 1.49 respectively. DSC and PXRD study revealed amorphous transition of CHR, which may help to increase its solubility and dissolution profile. In vivo pharmacokinetic study demonstrated more than 5-fold increase in relative bioavailability of CLPs. The in silico molecular docking study results demonstrated the electrostatic interaction between two polymers. The present study suggests that chitosan could protect and encapsulate chrysin which eventually enhances its cytotoxicity as well as bioavailability.